Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/ejbfCfbwocfaittRHgwP

January 31, 2013
Sign upForwardArchive
News for the PBM Industry

  Featured Story 
 Registration is now open for PCMA's Managed Markets Educational Forum!
Whether you are a seasoned managed markets executive or someone who supports the team, PCMA's Managed Markets Educational Forum will provide valuable education on fundamental, as well as complex and strategic issues relevant to professionals of all levels within pharma managed markets or market access divisions. Visit PCMA's website to learn more about our 2013 events!
 

  Legislative & Regulatory News 
  • Health insurance tax subsidies won't apply to dependents
    Dependents who can be covered through the employer of a family member won't benefit from the federal tax subsidies for lower-income Americans under the Affordable Care Act, according to rules announced by the Obama administration Wednesday. Dependents won't be able to benefit from subsidies even if the plan's cost is beyond the means of the family, the rules said. A hardship exemption from the individual mandate will apply to some people with low incomes, while illegal immigrants are exempted from penalties for not having insurance that begin next year. The Wall Street Journal (1/30) LinkedInFacebookTwitterEmail this Story
  • Report suggests ways to cut Medicare spending by $9.4T
    A 216-page Kaiser Family Foundation report suggests 150 changes to Medicare that together would reduce spending by $9.4 trillion over 10 years. Kaiser researchers reviewed literature and interviewed experts and policymakers to develop the report. Consensus areas included rewarding doctors for quality and reforming the formula by which health care providers are paid. The Washington Post/Wonkblog (1/30) LinkedInFacebookTwitterEmail this Story
  Drug Industry Spotlight 
  • Combo-drug-makers petition FDA on exclusivity period
    Ferring Pharmaceuticals and Gilead Sciences have petitioned the FDA to change how market exclusivity is granted for combination drugs. The agency grants five years' exclusivity if all active compounds in a combination drug are new and three years' exclusivity otherwise. The drugmakers say combination drugs are the same as new drugs and should be treated accordingly. Pharmalot.com/Pharma Blog (1/31) LinkedInFacebookTwitterEmail this Story
  Opinion, Commentary & Analysis 
 
  SmartQuote 
Any workout which does not involve a certain minimum of danger or responsibility does not improve the body -- it just wears it out."
--Norman Mailer,
American writer


LinkedInFacebookTwitter

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

 
Contact PCMA
Charles Cote
Assistant Vice President, Strategic Communications
(202) 207-3610

Twitter  Follow PCMA on Twitter
 
About PCMA
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.

 
 Recent PCMA SmartBrief Issues:   Lead Editor:  Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information